44 related articles for article (PubMed ID: 9282405)
21. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
Nayak S; Sashidhar RB; Bhat RV
Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
[TBL] [Abstract][Full Text] [Related]
22. Direct synthesis of aflatoxin B1-N7 guanine adduct: a reference standard for biological monitoring of dietary aflatoxin exposure in molecular epidemiological studies.
Vidyasagar T; Sujatha N; Sashidhar RB
Food Addit Contam; 1997 Jul; 14(5):457-67. PubMed ID: 9328530
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of mercapturic acid (N-acetyl-L-cysteine)-aflatoxin B1 adduct and its quantitation in rat urine by an enzyme immunoassay.
Nayak S; Tanuja P; Sashidhar RB
J AOAC Int; 2009; 92(2):487-95. PubMed ID: 19485208
[TBL] [Abstract][Full Text] [Related]
24. Enzyme immunoassay for aflatoxin B1-lysine adduct and its validation.
Sujatha N; Suryakala S; Rao BS
J AOAC Int; 2001; 84(5):1465-74. PubMed ID: 11601466
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of aflatoxin B1-N7-guanine adduct in urine by enzyme-linked immunosorbent assay coupled with immunoaffinity chromatography.
Vidyasagar T; Vyjayanthi V; Sujatha N; Rao BS; Bhat RV
J AOAC Int; 1997; 80(5):1013-22. PubMed ID: 9325579
[TBL] [Abstract][Full Text] [Related]
26. DNA damage by mycotoxins.
Wang JS; Groopman JD
Mutat Res; 1999 Mar; 424(1-2):167-81. PubMed ID: 10064859
[TBL] [Abstract][Full Text] [Related]
27. The structure of the aflatoxin B1-DNA adduct at N7 of guanine. Theoretical intercalation and covalent adduct models.
Bonnett M; Taylor ER
J Biomol Struct Dyn; 1989 Aug; 7(1):127-49. PubMed ID: 2510767
[TBL] [Abstract][Full Text] [Related]
28. The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1.
Groopman JD; Kensler TW
Pharmacol Ther; 1987; 34(2):321-34. PubMed ID: 3120202
[TBL] [Abstract][Full Text] [Related]
29. An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride.
Pottenger LH; Andrews LS; Bachman AN; Boogaard PJ; Cadet J; Embry MR; Farmer PB; Himmelstein MW; Jarabek AM; Martin EA; Mauthe RJ; Persaud R; Preston RJ; Schoeny R; Skare J; Swenberg JA; Williams GM; Zeiger E; Zhang F; Kim JH
Crit Rev Toxicol; 2014 Apr; 44(4):348-91. PubMed ID: 24494825
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of aflatoxin B1 lung tumorigenesis.
Massey TE; Smith GB; Tam AS
Exp Lung Res; 2000 Dec; 26(8):673-83. PubMed ID: 11195464
[TBL] [Abstract][Full Text] [Related]
31. An overview on possible links between aflatoxin B
Costa J; Lima N; Santos C
Mycotoxin Res; 2021 Aug; 37(3):205-214. PubMed ID: 34019215
[TBL] [Abstract][Full Text] [Related]
32. Molecular dosimetry of hepatic aflatoxin B1-DNA adducts: linear correlation with hepatic cancer risk.
Bechtel DH
Regul Toxicol Pharmacol; 1989 Aug; 10(1):74-81. PubMed ID: 2505337
[TBL] [Abstract][Full Text] [Related]
33. Measurement of DNA adducts by immunoassays.
Poirier MC; Weston A; Gupta-Burt S; Reed E
Basic Life Sci; 1990; 53():1-11. PubMed ID: 2282026
[No Abstract] [Full Text] [Related]
34. Determination of aflatoxin B1-DNA adduct in rat liver by enzyme immunoassay.
Vidyasagar T; Sujatha N; Sashidhar RB
Analyst; 1997 Jun; 122(6):609-13. PubMed ID: 9282405
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
